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Abstract
Background: Suicide is a leading cause of death worldwide. Mental disorders are among the strongest predictors of suicide;
however, little is known about which disorders are uniquely predictive of suicidal behavior, the extent to which disorders
predict suicide attempts beyond their association with suicidal thoughts, and whether these associations are similar across
developed and developing countries. This study was designed to test each of these questions with a focus on nonfatal
suicide attempts.
Methods and Findings: Data on the lifetime presence and age-of-onset of Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (DSM-IV) mental disorders and nonfatal suicidal behaviors were collected via structured face-to-face
interviews with 108,664 respondents from 21 countries participating in the WHO World Mental Health Surveys. The results
show that each lifetime disorder examined significantly predicts the subsequent first onset of suicide attempt (odds ratios
[ORs]=2.9–8.9). After controlling for comorbidity, these associations decreased substantially (ORs=1.5–5.6) but remained
significant in most cases. Overall, mental disorders were equally predictive in developed and developing countries, with a
key difference being that the strongest predictors of suicide attempts in developed countries were mood disorders, whereas
in developing countries impulse-control, substance use, and post-traumatic stress disorders were most predictive.
Disaggregation of the associations between mental disorders and nonfatal suicide attempts showed that these associations
are largely due to disorders predicting the onset of suicidal thoughts rather than predicting progression from thoughts to
attempts. In the few instances where mental disorders predicted the transition from suicidal thoughts to attempts, the
significant disorders are characterized by anxiety and poor impulse-control. The limitations of this study include the use of
retrospective self-reports of lifetime occurrence and age-of-onset of mental disorders and suicidal behaviors, as well as the
narrow focus on mental disorders as predictors of nonfatal suicidal behaviors, each of which must be addressed in future
studies.
Conclusions: This study found that a wide range of mental disorders increased the odds of experiencing suicide ideation.
However, after controlling for psychiatric comorbidity, only disorders characterized by anxiety and poor impulse-control
predict which people with suicide ideation act on such thoughts. These findings provide a more fine-grained understanding
of the associations between mental disorders and subsequent suicidal behavior than previously available and indicate that
mental disorders predict suicidal behaviors similarly in both developed and developing countries. Future research is needed
to delineate the mechanisms through which people come to think about suicide and subsequently progress from ideation
to attempts.
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Suicide is among the leading causes of death and disease burden
around the world [1–4]. Although there have been significant
advances in suicide research as well as increases in the treatment of
suicidal people, the rate of suicidal behaviors has not changed as a
result [1,5]. The seriousness of this problem has led the World
Health Organization (WHO) [6], the U.S. Surgeon General [7],
the U.S. Department of Health and Human Services [8], and the
Institute of Medicine [2] to call for research aimed at better
understanding the risk factors for suicide and nonfatal suicidal
behavior. Nonfatal suicidal behaviors are important because they
are among the most powerful predictors of subsequent suicide
deaths [9–12] and because they are significant outcomes in their
own right that cause substantial distress.
Most research aimed at identifying risk factors for nonfatal
suicidal behaviors has focused on the importance of prior mental
disorders. To date, dozens of studies have clearly shown that
mental disorders, particularly depressive disorders, are among the
strongest risk factors for suicide attempts and suicide deaths [12–
14]. Despite this knowledge, several important questions remain
regarding how and why mental disorders are associated with
suicidal behavior. First, little is known about which disorders are
uniquely predictive of suicidal behavior. Most studies have
examined the bivariate associations between individual disorders
and suicidal behavior [15–18] and in doing so have shown that
virtually all mental disorders are associated with an increased risk
of suicidal behavior [5,12,19]. However, because mental disorders
are highly comorbid [20], it is possible that many of the observed
associations are due to the true effects of only a small number of
disorders. For instance, several studies have reported that panic
disorder is a significant risk factor for suicide attempts [15,21].
Other studies, though, have shown that this association is no
longer significant after accounting for a broad range of comorbid
disorders [22–24]. Obtaining a clearer picture regarding which
disorders are uniquely related to suicidal behavior is necessary in
order to better understand, predict, and treat suicidal behavior
and requires that future studies more carefully examine and
control for the effects of comorbidity.
Second, surprisingly little is known about the extent to which
mental disorders predict suicide attempts beyond their association
with suicide ideation (i.e., suicidal thoughts). Several recent studies
have suggested that although mental disorders are strongly
predictive of suicide ideation, they are less useful in predicting
which people with suicide ideation go on to make suicide plans and
attempts [25,26]. If this initial finding is replicated more broadly, an
important next question is whether some disorders are more useful
in predicting suicide ideation, while others are more predictive of
acting on such thoughts. Providing greater clarity regarding how
different mental disorders relate to distinct stages of the progression
to suicide attempts would not only advance knowledge regarding
how suicidal behavior develops, but would provide valuable
information for clinical risk assessment and treatment.
Third, there is debate regarding the generality of prior findings
on the association between mental disorders and suicidal behavior.
Previous studies have been conducted almost exclusively in
developed countries [27–29], and several recent studies in
developing countries have suggested that mental disorders are less
predictive of suicidal behaviors in such countries [30,31].
Although, one recent study reported no difference between
developed and developing countries when similar assessment
methods are used cross-nationally [19]. Accurate data on the risk
factors for suicidal behavior in both developed and developing
countries are needed to develop more adequate screening,
prevention, and intervention programs around the world [2,3,30].
The current study was designed to address each of these
limitations by conducting a comprehensive cross-national analysis
of the associations between lifetime history and age-of-onset of
mental disorders and the subsequent first onset of nonfatal suicidal
behaviors using data from the WHO World Mental Health
(WMH) Surveys—a series of coordinated epidemiological surveys
carried out in 21 countries around the world [32,33]. The
objectives of this study were to examine the unique associations
between prior mental disorders and the subsequent first onset of
suicidal behaviors, to test the effects of comorbidity on suicidal
behaviors, and to decompose the associations between mental
disorders and suicidal behaviors by considering effects of mental
disorders on suicide ideation, plans among ideators, and suicide
attempts separately among ideators with and without suicide
plans. This study extends the work of prior studies that have
reported on the bivariate associations between mental disorders
and suicidal behaviors in a subset of WMH countries [19] and that
have tested multivariate models of these associations within
individual WMH countries [26]. The size and representativeness
of the current study sample provided a unique opportunity to test
complex multivariate models predicting the onset of suicidal
behaviors and to examine the consistency of the observed effects
between developed and developing countries.
Methods
Respondent Samples
The WMH surveys were carried out in 21 countries in: Africa
(Nigeria; South Africa); the Americas (Brazil; Colombia; Mexico;
United States), Asia and the Pacific (India; Japan; New Zealand;
Beijing, Shanghai, and Shenzhen in the Peoples Republic of
China), Europe (Belgium; Bulgaria; France; Germany; Italy; the
Netherlands; Romania; Spain; Ukraine); and the Middle East
(Israel; Lebanon). The World Bank [34] classifies Brazil, Bulgaria,
China, Colombia, India, Lebanon, Mexico, Nigeria, Romania,
South Africa, and Ukraine as low- and lower-middle income
countries (i.e., developing); and all other survey countries as
higher-middle or high-income countries (i.e., developed). Respon-
dents were selected in most WMH countries using a stratified
multistage clustered-area probability sampling strategy. The total
sample size was 108,664, with individual country sample sizes
ranging from 2,357 in Romania to 12,790 in New Zealand. The
weighted average response rate across all countries was 73.3% (see
Table 1 for sample and survey characteristics).
Procedures
All surveys were conducted face-to-face by trained lay
interviewers. Standardized interviewer training procedures,
WHO translation protocols for all study materials, and quality
control procedures for interviewer and data accuracy, which have
been consistently employed across all WMH countries, are
described in more detail elsewhere [33,35,36]. All respondents
completed a part I interview that contained assessments of the
lifetime prevalence and age-of-onset of core mental disorders as
well as the assessment of the lifetime prevalence and ages-of-onset
of three nonfatal suicidal behaviors—suicidal ideation, suicide
plans, and suicide attempts. All part I respondents who met
criteria for any disorder and a probability subsample of
approximately 25% of the rest of the respondents were
administered a part II interview that assessed potential correlates
and disorders of secondary interest (n=54,992). The part II data,
Mental Disorders and Suicidal Behavior
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Country Survey
a Sample Characteristics
b Field Dates
Age
Range (y)
n
(Part 1)
n
(Part II)
n (Part II and
Age#44 y
c)
Response
Rate
d,e
I. Developed
Belgium ESEMeD Stratified multistage clustered probability
sample of individuals residing in households
from the national register of Belgium
residents. NR
2001–2002 18+ 2,419 1,043 486 50.6
France ESEMeD Stratified multistage clustered sample of
working telephone numbers merged with
a reverse directory (for listed numbers).
Initial recruitment was by telephone, with
supplemental in-person recruitment in
households with listed numbers. NR
2001–2002 18+ 2,894 1,436 727 45.9
Germany ESEMeD Stratified multistage clustered probability
sample of individuals from community
resident registries. NR
2002–2003 18+ 3,555 1,323 621 57.8
Israel NHS Stratified multistage clustered area
probability sample of individuals from
a national resident register. NR
2002–2004 21+ 4,859 — — 72.6
Italy ESEMeD Stratified multistage clustered probability
sample of individuals from municipality
resident registries. NR
2001–2002 18+ 4,712 1,779 853 71.3
Japan WMHJ
2002–2006
Unclustered two-stage probability sample
of individuals residing in households in ten
metropolitan areas (Fukiage, Higashi-ichiki,
Ichiki, Kushikino, Nagasaki, Okayama, Sano,
Tamano, Tendo, and Tochigi)
2002–2006 20+ 3,416 1,305 425 59.2
Netherlands ESEMeD Stratified multistage clustered probability
sample of individuals residing in households
that are listed in municipal postal registries. NR
2002–2003 18+ 2,372 1,094 516 56.4
New Zealand NZMHS Stratified multistage clustered area probability
sample of household residents. NR
2004–2005 18+ 12,790 7,312 — 73.3
Spain ESEMeD Stratified multistage clustered area probability
sample of household residents. NR
2001–2002 18+ 5,473 2,121 960 78.6
United States NCS-R Stratified multistage clustered area probability
sample of household residents. NR
2002–2003 18+ 9,281 5,691 3,196 70.9
II. Developing
Brazil Sa ˜o Paulo
Megacity
Stratified multistage clustered area
probability sample of household
residents in the Sa ˜o Paulo metropolitan
area.
2005–2007 18+ 5,037 2,942 — 81.3
Bulgaria NSHS Stratified multistage clustered area probability
sample of household residents. NR
2003–2007 18+ 5,318 2,233 741 72.0
Colombia NSMH Stratified multistage clustered area probability
sample of household residents in all urban
areas of the country (approximately 73% of
the total national population)
2003 18–65 4,426 2,381 1,731 87.7
India WMHI Stratified multistage clustered area probability
sample of household residents in Pondicherry
region. NR
2003–2005 18+ 2,992 1,373 825 98.6
Lebanon LEBANON Stratified multistage clustered area probability
sample of household residents. NR
2002–2003 18+ 2,857 1,031 595 70.0
Mexico M-NCS Stratified multistage clustered area probability
sample of household residents in all urban
areas of the country (approximately 75% of
the total national population).
2001–2002 18–65 5,782 2,362 1,736 76.6
Nigeria NSMHW Stratified multistage clustered area probability
sample of households in 21 of the 36 states
in the country, representing 57% of the
national population. The surveys were
conducted in Yoruba, Igbo, Hausa, and
Efik languages.
2002–2003 18+ 6,752 2,143 1,392 79.3
PRC B-WMH
S-WMH
Stratified multistage clustered area probability
sample of household residents in the Beijing
and Shanghai metropolitan areas.
2002–2003 18+ 5,201 1,628 859 74.7
Mental Disorders and Suicidal Behavior
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this differential sampling of part I respondents into part II, for
differential probabilities of selection within households, and for
discrepancies between sample and Census population distributions
of socio-demographic variables. These weighting procedures make
the part II sample representative of the entire population despite
the undersampling of part I respondents who did not have any
core Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV) disorder. Informed consent was obtained before
beginning interviews in all countries. Procedures for obtaining
informed consent and protecting human subjects were approved
and monitored for compliance by the Institutional Review Boards
of organizations coordinating surveys in each country.
Measures
DSM-IV mental disorders. Lifetime mental disorders were
assessed using the WHO Composite International Diagnostic
Interview (CIDI) Version 3.0, a fully structured diagnostic
interview administered by trained lay interviewers [33]. The 16
mental disorders assessed in the CIDI were anxiety disorders
(panic, generalized anxiety, phobias, posttraumatic stress [PTSD],
and separation anxiety), mood disorders (major depressive,
dysthymic, and bipolar), impulse-control disorders (oppositional-
defiant, conduct, attention-deficit/hyperactivity, and intermittent
explosive), and substance use disorders (alcohol and illicit drug
abuse and dependence). Diagnoses were made using organic
exclusion rules but without using diagnostic hierarchy rules,
leading to an inflation in the estimates of comorbidity compared to
those that would have been made if hierarchy rules had been used.
Clinical reappraisal studies found CIDI diagnoses to have
generally good concordance with blinded clinical diagnoses
based on the Structured Clinical Interview for DSM-IV [37] in
probability subsamples of respondents from the France, Italy,
Spain, and US surveys [38,39]. Concordance in the assessment of
comorbidity, though, was not evaluated in these studies, nor were
CIDI clinical reappraisal studies carried out in any of the
developing countries included in the WMH series.
Suicidal behavior. Lifetime nonfatal suicidal behaviors were
assessed using the Suicidality Module of the CIDI [33], which
includes assessments of the occurrence and age-of-onset of suicide
ideation, plans, and attempts. This assessment was included in the
part I sample, however, as several of the mental disorders were
assessed in part II of the CIDI, all multivariate analyses were
restrictedto part II cases.As notedabove, though,theweighted part
II sample is representative of the population and includes 100% of
respondents with core DSM-IV disorders, which means that there is
no loss in generality of results due to the focus on part II
respondents. Consistent with our goal of examining relationships of
mental disorders with a continuum of suicidal behaviors, we
considered five dated lifetime outcomes in a series of nested survival
analyses (see below for analysis methods): (1) first suicide attempt in
the total sample; (2) first onset of suicide ideation in the total sample;
(3) first suicide plan among respondents with a lifetime history of
ideation; (4) first suicide attempt among respondents with a history
of a lifetime suicide plan; and (5) first unplanned suicide attempt
among respondents with a history of ideation.
Analysis Methods
We first estimated the prevalence of each temporally prior
mental disorder among respondents with each of the five suicidal
Country Survey
a Sample Characteristics
b Field Dates
Age
Range (y)
n
(Part 1)
n
(Part II)
n (Part II and
Age#44 y
c)
Response
Rate
d,e
PRC Shenzhen Stratified multistage clustered area probability
sample of household residents and temporary
residents in the Shenzhen area.
2006–2007 18+ 7,132 2,475 2,190 80.0
Romania RMHS Stratified multistage clustered area probability
sample of household residents. NR
2005–2006 18+ 2,357 — — 70.9
South Africa SASH Stratified multistage clustered area probability
sample of household residents. NR
2003–2004 18+ 4,315 — — 87.1
Ukraine CMDPSD Stratified multistage clustered area probability
sample of household residents. NR
2002 18+ 4,724 1,719 714 78.3
aB-WMH, The Beijing World Mental Health Survey; CMDPSD, Comorbid Mental Disorders during Periods of Social Disruption; ESEMeD, The European Study Of The
Epidemiology Of Mental Disorders; LEBANON, Lebanese Evaluation of the Burden of Ailments and Needs of the Nation; M-NCS, The Mexico National Comorbidity
Survey; NCS-R, The US National Comorbidity Survey Replication; NHS, Israel National Health Survey; NSHS, Bulgaria National Survey of Health and Stress; NSMH, The
Colombian National Study of Mental Health; NSMHW, The Nigerian Survey of Mental Health and Wellbeing; NZMHS, New Zealand Mental Health Survey; RMHS,
Romania Mental Health Survey; SASH, South Africa Stress and Health Study; S-WMH, The Shanghai World Mental Health Survey; WMHI, World Mental Health India;
WMHJ2002–2006, World Mental Health Japan Survey.
bMost WMH surveys are based on stratified multistage clustered area probability household samples in which samples of areas equivalent to counties or municipalities
in the US were selected in the first stage followed by one or more subsequent stages of geographic sampling (e.g., towns within counties, blocks within towns,
households within blocks) to arrive at a sample of households, in each of which a listing of household members was created and one or two people were selected from
this listing to be interviewed. No substitution was allowed when the originally sampled household resident could not be interviewed. These household samples were
selected from census area data in all countries other than France (where telephone directories were used to select households) and the Netherlands (where postal
registries were used to select households). Several WMH surveys (Belgium, Germany, Italy) used municipal resident registries to select respondents without listing
households. The Japanese sample is the only totally unclustered sample, with households randomly selected in each of the four sample areas and one random
respondent selected in each sample household. 16 of the 22 surveys are based on nationally representative (NR) household samples, while two others are based on NR
household samples in urbanized areas (Colombia, Mexico).
cBrazil, Israel, New Zealand, Romania, and South Africa did not have an age restricted part II sample. All other countries, with the exception of India, Nigeria, the People’s
Republic of China, and Ukraine (which were age restricted to #39 y) were age restricted to #44 y.
dThe response rate is calculated as the ratio of the number of households in which an interview was completed to the number of households originally sampled,
excluding from the denominator households known not to be eligible either because of being vacant at the time of initial contact or because the residents were
unable to speak the designated languages of the survey.
eThe weighted average response rate is 73%.
doi:10.1371/journal.pmed.1000123.t001
Table 1. Cont.
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disorders was examined using individual-level retrospective age-of-
onset reports for both mental disorders and suicidal behaviors.
Next, the associations among temporally prior mental disorders
(i.e., time-varying covariates) and subsequent suicidal behaviors
were estimated using discrete-time survival models with person-
year as the unit of analysis [40]. In this approach, each year of life
of each respondent up to and including the year of first onset of the
outcome is treated as a separate observational record, with years
prior to the onset coded 0 on the outcome variable and the year of
onset coded 1 on the outcome variable. All years subsequent to
age-of-onset of the outcome are excluded from the analysis. All
years of life up to the age at interview are included for respondents
who never experienced the outcome. Each person-year record is
coded for the respondent’s age in that year, age at interview, sex,
and prior history of each mental disorder as of that age. This data
array is analyzed using logistic regression methods, with dummy
predictor variables for age in the person-year used as control
variables along with predictors for age at interview, sex, and
lifetime history of mental disorders as of the person-year in
predicting first onset of the outcome. The logistic regression
coefficients can be interpreted as survival coefficients because of
the exclusion from the data array of person-years after the onset of
the outcome.
We used this approach to estimate discrete-time survival models
that were bivariate (i.e., including only one disorder at a time) as
well as models that were multivariate (i.e., including all disorders
simultaneously) in predicting each suicidal behavior. These models
all controlled for respondent age at interview (both linear and
quadratic terms in addition to a series of dummy variables for
broad age cohort groups of respondents in the age ranges 18–29,
30–44, 45–59, and 60+ y at the time of interview), age in each
person-year of the survival data file, and sex. Results regarding the
associations between these control variables and the outcomes
have been reported previously [19] and will not be repeated here.
We also estimated a series of models that allowed for multiplicative
interactions among comorbid disorders. Because 16 different
mental disorders were included as predictors in the analyses, the
number of possible interactions was substantial (2
16217=65,519),
and so we imposed some structure on the interactions to generate
models with stable estimates.
We began with a model with summary dummy variables for the
total number of disorders experienced by each respondent (e.g.,
separate dummy predictor variables to distinguish respondents with
exactly two disorders, exactly three, …, etc.). This model assumed
that interactions were constant across type of disorder and were
influenced only by number of disorders (i.e., that the 120 odds ratios
[ORs] of the 16615/2 logically possible two-way interactions could
all be considered the same; that the 560 ORs of the 16615614/6
logically possible three-way interactions could all be considered the
same, etc.). Next, more complex models were estimated allowing for
interactions between eachtypeof disorder and number of comorbid
disorders. The simple model assuming constant interactions was a
good approximation of the data, so that model was used in
subsequent analyses. Finally, population attributable risk propor-
tions (PARPs) due to each class of disorders were calculated on the
basis of the results of the simple interaction model.
Survival coefficients were exponentiated to generate ORs and
their standard errors for ease of interpretation. Standard errors of
prevalence estimates and survival coefficients were estimated with
the Taylor series method [41] using SUDAAN software [42] to
adjust for weighting and clustering. Multivariate significance was
evaluated with Wald x
2 tests based on design-corrected coefficient
variance–covariance matrices. All significance tests were evaluated
using 0.05-level two-sided tests. All analyses were conducted two
times—one time each for developed and developing countries—in
order to test the consistency of the observed effects.
Results
Prevalence of Temporally Prior Mental Disorders among
those with Suicidal Behavior
Approximately half of people who had seriously considered
killing themselves reported a prior lifetime DSM-IV disorder in
both developed (51.8%) and developing (42.9%) countries
(x
2
1=16.9, p,0.001). Mental disorders were even more prevalent
among respondents who went on to make a suicide attempt
(65.7% and 54.6%, respectively; x
2
1=15.4, p,0.001). Among
respondents with suicide ideation, the prevalence of a mental
disorder was higher among those making a planned suicide
attempt (68.6% and 59.6%; x
2
1=6.7, p=0.009) than among those
making an unplanned (i.e., impulsive) attempt (60.5% and 44.6%;
x
2
1=12.6, p,0.001). The rates of mental disorders were higher
among those making a planned attempt than an unplanned
attempt in both developed (x
2
1=5.4, p=0.020) and developing
(x
2
1=15.9, p,0.001) countries. This rate suggests that impulsive
attempts may be more influenced by other factors such as stressful
life events (see Tables S1 and S2 for more detailed results).
Associations of Temporally Primary DSM-IV Disorders
with Suicide Attempts
Bivariate survival models reveal that each of the 16 DSM-IV
disorders examined is significantly associated with the onset of a
subsequent suicide attempt, with ORs ranging from 2.9 (specific
phobia) to 7.1 (bipolar disorder) (interquartile range [IQR]=3.7–
5.5) in developed countries and from 2.6 (agoraphobia) to 8.9
(conductdisorder)(IQR=3.7–6.9)indevelopingcountries(Tables2
and 3). These ORs all decreased in additive multivariate models
that test the unique associations between disorders and suicide
attempt in both developed countries, where ORs range from 0.9
(dysthymia) to 2.9 (major depression) (IQR=1.3–2.0), and in
developing countries, where ORs range from 1.3 (agoraphobia and
OCD) to 3.3 (PTSD) (IQR=1.4–2.2)—although 30 of the 32 ORs
remained greater than 1.0, and 18 remain statistically significant.
Next, simple interactive multivariate models were estimated that
included one dummy variable for each of the 16 disorders plus
additional dummy variables for each number of disorders (e.g.,
exactly two prior disorders, exactly three, etc.). The ORs for
individual disorders in these models can be interpreted as the
relative odds of a subsequent suicide attempt among respondents
witha pure disorder(i.e.,onlythis onedisorder)versusthosewithno
disorders. Similar to the additive multivariate model, pure disorders
have consistently significant ORs that are generally comparable in
magnitude in developed countries, where ORs range from 1.5
(dysthymia) to 3.5 (bipolar disorder) (IQR=1.9–2.6), and in
developing countries, where ORs range from 2.1 (agoraphobia) to
5.6 (PTSD) (IQR=2.7–3.7). In developed countries, the disorders
with the strongest association with suicide attempts in addition to
bipolar disorder weredepression (OR=3.2), and PTSD (OR=3.0),
whereas in developing countries, the strongest predictors in addition
to PTSD were conduct disorder (OR=4.8), and drug abuse/
dependence (OR=4.0).
Associations of Number of Comorbid Disorders with
Suicide Attempts
The model that included dummy variables for number of
disorders but not types of disorders documented a strong dose-
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suicide behaviors, with ORs increasing in developed countries from
3.9 for one disorder up to 28.2 for six or more disorders (compared
to respondents with no disorder) (Table 4). The same pattern was
observed in developing countries, with ORs increasing from 3.5 in
those with one disorder up to 32.1 in those with six or more
disorders (Table 5). Notably, though, the ORs increased at a
decreasing rate as number of disorders increases, which means that
the incremental impact of each additional disorder decreased as the
total number of disorders increased. This can be seen in the results
of the more elaboratemodelthat includes predictors for the 16types
of disorders (i.e., as in Tables 2 and 3) in addition to predictors for
number of disorders, where the ORs associated with number of
disorders were generally lower than 1.0 and became smaller as the
number of disorders becomes larger. This is known as a subadditive
interaction; that is, a situation in which the effects of comorbid
disorders are less than the sum of their individual effects due to the
incremental predictive powerof individual disorders decaying as the
number of comorbid disorders increases. It is noteworthy that even
though this decay is generally monotonic, formal significance tests
found that the assumption of the decay being linear can be rejected.
(Detailedresults areavailable onrequest.) That is why weincludeda
series of dummy variables rather than a single continuous 0–16
measure to describe number of disorders.
The model that includes the 16 dummy variables for types of
disorder as well as the dummy variables for number of disorders as
predictors implicitly assumes that interactions are identical for all
comorbid profiles involving the same number of disorders. This
Table 2. Survival models of the associations between DSM-IV disorders and a subsequent suicide attempt—developed countries.
Response Variable: Lifetime Attempt among Part II Sample (n=27,963)
Bivariate Models
a Multivariate Additive Model
b Multivariate Interactive Model
c
DSM-IV Disorders OR (95% CI) OR (95% CI) OR (95% CI)
I. Anxiety disorders
Panic disorder 5.1 (4.0–6.4)* 1.5 (1.1–2.1)* 2.3 (1.6–3.3)*
GAD 5.6 (4.6–6.7)* 1.8 (1.4–2.3)* 2.5 (1.9–3.4)*
Specific phobia 2.9 (2.5–3.4)* 1.6 (1.4–1.9)* 1.9 (1.5–2.4)*
Social phobia 3.8 (3.2–4.4)* 1.5 (1.2–1.8)* 1.9 (1.4–2.5)*
PTSD 6.5 (5.4–7.6)* 2.1 (1.7–2.7)* 3.0 (2.3–3.8)*
SAD 3.5 (2.8–4.4)* 1.0 (0.8–1.3) 1.6 (1.2–2.1)*
Agoraphobia 3.7 (2.7–5.0)* 1.4 (0.9–2.1) 2.2 (1.4–3.4)*
Any anxiety disorder 4.6 (4.0–5.3)* — —
II. Mood disorders
MDD 5.8 (5.0–6.8)* 2.9 (2.4–3.6)* 3.2 (2.5–4.2)*
Dysthymia 5.1 (4.0–6.6)* 0.9 (0.6–1.3) 1.5 (1.0–2.2)*
Bipolar disorder 7.1 (5.5–9.3)* 2.3 (1.6–3.3)* 3.5 (2.4–5.3)*
Any Mood disorder 5.9 (5.1–6.8)* — —
III. Impulse-control disorders
ODD 5.3 (4.1–6.7)* 1.6 (1.1–2.2)* 2.2 (1.6–3.0)*
Conduct disorder 4.8 (3.6–6.4)* 1.5 (1.1–2.1)* 2.1 (1.4–3.0)*
ADHD 4.6 (3.5–6.1)* 1.4 (1.0–1.9) 1.9 (1.3–2.7)*
IED 3.3 (2.5–4.3)* 1.2 (0.8–1.7) 1.8 (1.2–2.5)*
Any impulse-control disorder 4.3 (3.5–5.3)* — —
IV. Substance use disorders
Alcohol abuse or dependency 4.4 (3.7–5.3)* 2.1 (1.6–2.6)* 2.6 (1.9–3.5)*
Drug abuse or dependency 4.9 (3.8–6.2)* 1.3 (0.9–1.8) 2.0 (1.4–2.8)*
Any substance use disorder 4.8 (4.0–5.8)* —
V. Any disorder 6.4 (5.5–7.5)* —
Overall group effect x
2 (p-value)
d 1,151.6 (,0.001)* 160.5 (,0.001)*
Empty cells indicate the disorder specified in the row was not included in the model.
aBivariate models (each disorder in a separate discrete time survival model) include the following controls: age, age-squared, age cohorts, sex, and person-year.
bMultivariate additive model (all disorders together in a discrete time survival model) includes the following covariates: age, age-squared, age cohorts, sex, and person-
year.
cMultivariate interactive model (all disorders together in a discrete time survival model controlling for number of disorders as interactions) includes the following
covariates: age, age-squared, age cohorts, sex, and person-year.
dThe group effect x
2 tests the set of coefficients for type of disorder for significance, while the individual x
2 only test presence versus absence of each DSM-IV/CIDI
disorder.
*Significant at the 0.05 level, two-sided test.
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; CI, confidence interval; GAD, Generalized Anxiety Disorder; IED, Intermittent Explosive Disorder; MDD,
Major Depressive Disorder; OCD, Obsessive Compulsive Disorder; ODD, Oppositional Defiant Disorder; SAD, Separation Anxiety Disorder.
doi:10.1371/journal.pmed.1000123.t002
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also evaluated more elaborate models that considered distinct
interactions for specific disorders with numbers of other disorders.
However, these models did not improve over the simpler
interactive model. We consequently based subsequent analyses
on the simple interactive model (see Tables S3 and S4 for more
detailed results).
Unique Associations among Mental Disorders and Each
Suicidal Outcome
In order to increase our understanding of how each mental
disorder relates to each type of suicidal behavior, we next
disaggregated the associations between each disorder and suicide
attempts into five components focused on the prediction of
subsequent (to the onset of the mental disorders) first onset of
ideation in the total sample, onset of plans among ideators, and
onset of attempts among ideators with and without a suicide plan
(Tables 6 and 7). Analyses revealed that the most powerful and
consistent associations are with suicide ideation (all 32 ORs are
positive and statistically significant), with ORs that are relatively
consistent across developed (ORs=1.7–3.5, IQR=1.9–2.5), and
developing (ORs=1.8–3.9, IQR=2.3–3.4) countries. Among
respondents with suicide ideation, mental disorders were much
less powerful in predicting the subsequent onset of suicide plans in
Table 3. Survival models of the associations between DSM-IV disorders and a subsequent suicide attempt—developing countries.
Response Variable: Lifetime Attempt among Part II Sample (n=26,959)
Bivariate Models
a Multivariate Additive Model
b Multivariate Interactive Model
c
DSM-IV Disorders OR (95% CI) OR (95% CI) OR (95% CI)
I. Anxiety disorders
Panic disorder 5.0 (3.4–7.3)* 1.6 (0.9–2.9) 3.0 (1.7–5.4)*
GAD 5.4 (3.9–7.5)* 1.4 (0.9–2.2) 2.9 (1.8–4.6)*
Specific phobia 3.3 (2.8–4.0)* 1.9 (1.5–2.3)* 2.6 (2.0–3.4)*
Social phobia 3.9 (3.0–5.0)* 1.7 (1.2–2.4)* 2.9 (2.0–4.0)*
PTSD 8.3 (6.0–11.6)* 3.3 (2.1–5.1)* 5.6 (3.5–8.8)*
OCD 3.4 (2.0–6.1)* 1.3 (0.7–2.4) 2.3 (1.3–4.2)*
SAD 2.9 (2.1–4.0)* 1.4 (1.0–1.9) 2.4 (1.7–3.4)*
Agoraphobia 2.6 (1.8–3.7)* 1.3 (0.9–1.8) 2.1 (1.4–3.0)*
Any anxiety disorder 3.7 (3.2–4.4)* — —
II. Mood disorders
MDD 5.1 (4.2–6.1)* 2.2 (1.7–2.9)* 3.2 (2.4–4.3)*
Dysthymia 7.1 (4.8–10.7)* 1.8 (1.0–3.4) 3.5 (1.9–6.6)*
Bipolar disorder 6.7 (4.4–10.0)* 1.4 (0.8–2.4) 3.2 (1.8–5.4)*
Any mood disorder 5.0 (4.2–6.0)* — —
III. Impulse-control disorders
ODD 6.7 (4.1–10.9)* 1.9 (1.0–3.6) 3.6 (2.0–6.5)*
Conduct disorder 8.9 (5.6–14.2)* 2.4 (1.2–4.9)* 4.8 (2.5–9.1)*
ADHD 4.9 (3.2–7.7)* 1.5 (0.8–2.8) 2.8 (1.6–4.9)*
IED 4.7 (3.7–6.2)* 2.0 (1.4–2.9)* 3.3 (2.3–4.7)*
Any Impulse-control disorder 5.4 (4.3–6.9)* — —
IV. Substance use disorders
Alcohol abuse or dependency 4.8 (3.7–6.1)* 2.5 (1.8–3.6)* 3.7 (2.6–5.4)*
Drug abuse or dependency 7.5 (5.4–10.4)* 2.1 (1.2–3.6)* 4.0 (2.5–6.4)*
Any substance use disorder 5.4 (4.3–6.8)* — —
V. Any disorder 5.1 (4.3–6.0)* — —
Overall group effect x
2 (p-value)
d — 656.8 (,0.001)* 159.3 (,0.001)*
Empty cells indicate the disorder specified in the row was not included in the model.
aBivariate models (each disorder in a separate discrete time survival model) include the following controls: age, age-squared, age cohorts, sex, and person-year.
bMultivariate additive model (all disorders together in a discrete time survival model) includes the following covariates: age, age-squared, age cohorts, sex, and person-
year.
cMultivariate interactive model (all disorders together in a discrete time survival model controlling for number of disorders as interactions) includes the following
covariates: age, age-squared, age cohorts, sex, and person-year.
dThe group effect x
2 tests the set of coefficients for type of disorder for significance, while the individual x
2 only test presence versus absence of each DSM-IV/CIDI
disorder.
*Significant at the 0.05 level, two-sided test.
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; CI, confidence interval; GAD, Generalized Anxiety Disorder; IED, Intermittent Explosive Disorder; MDD,
Major Depressive Disorder; OCD, Obsessive Compulsive Disorder; ODD, Oppositional Defiant Disorder; PTSD, Posttraumatic Stress Disorder; SAD, Separation Anxiety
Disorder.
doi:10.1371/journal.pmed.1000123.t003
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IQR=1.1–1.4) or developing (only seven are significant,
ORs=0.9–2.5, IQR=1.2–1.7) countries. Mental disorders were
similarly less powerful in predicting planned attempts (eight of the
16 ORs were significant in developed countries, ORs=0.8–2.6,
IQR=1.2–1.4; only four were significant in developing countries,
ORs=1.1–3.2, IQR=1.3–1.7) and unplanned attempts among
ideators (seven of the 16 ORs were significant in developed
countries, ORs=0.7–2.2, IQR=1.1–1.9; only two were signifi-
cant in developing countries, ORs=0.7–3.1, IQR=0.9–1.9). In
the case of comorbidity, similar to the models predicting suicide
attempts in the total sample, we found ORs significantly less than
1.0 for comorbidities involving large numbers of disorders in
predicting suicide ideation and planned attempts in both
developed and developing countries. However, these subadditive
comorbidities were not observed consistently in the prediction of
plans or unplanned attempts among those with suicide ideation,
which means that the multivariate effects of comorbid disorders
are largely additive in predicting these outcomes.
An examination of the predictive associations of individual
disorders in developed countries revealed that depression is among
the strongest predictors of suicide ideation (OR=3.3), but is much
less powerful in predicting progression from ideation to plans
(OR=1.5), planned attempts (OR=1.5), or unplanned attempts
among ideators (OR=1.2). Instead, the strongest predictors of
suicide attempts among ideators were disorders characterized by
anxiety and impulse-control problems. This was especially true for
unplanned attempts, for which PTSD (OR=2.1), bipolar disorder
(OR=2.0), and conduct disorder (OR=2.2) were the strongest
predictors and the only disorders with ORs greater than 2.0.
Table 4. Survival models of the associations between number of prior DSM-IV disorders and a subsequent suicide attempt—
developed countries.
Response Variable: Lifetime Attempt among Part II Sample (n=27,963)
Bivariate Models
a Multivariate Interactive Model
b
Number of DSM-IV Disorders OR (95% CI) OR (95% CI)
Exactly 1 3.9 (3.2–4.7)* —
Exactly 2 7.4 (6.0–9.1)* 1.1 (0.8–1.7)
Exactly 3 14.2 (10.9–18.3)* 1.0 (0.5–1.8)
Exactly 4 16.6 (12.6–21.8)* 0.5 (0.2–1.0)
Exactly 5 17.9 (12.7–25.4)* 0.2 (0.1–0.6)*
$6 28.2 (20.3–39.3)* 0.1 (0.0–0.2)*
x
2 (p-value)
c 798.4 (,0.001)* 113.5 (,0.001)*
aBivariate discrete time survival models include the following covariates: age, age-squared, age cohort, sex, and person-year.
bMultivariate interactive model (includes number of disorders and individual DSM-IV/CIDI disorders together in a discrete time survival model) includes the following
covariates: age, age-squared, age cohorts, sex, and person-year.
cThe group effect x
2 tests the set of coefficients for number of disorders for significance, while the individual x
2 only test presence versus absence of each specific
number of disorders.
*Significant at the 0.05 level, two-sided test.
doi:10.1371/journal.pmed.1000123.t004
Table 5. Survival models of the associations between number of prior DSM-IV disorders and a subsequent suicide attempt—
developing countries.
Response Variable: Lifetime Attempt among Part II Sample (n=26,959)
Bivariate Models
a Multivariate Interactive Model
b
Number of DSM-IV Disorders OR (95% CI) OR (95% CI)
Exactly 1 3.5 (2.9–4.2)* —
Exactly 2 6.8 (5.2–8.8)* 0.7 (0.5–1.0)
Exactly 3 9.4 (6.9–12.9)* 0.3 (0.2–0.6)*
Exactly 4 16.8 (11.2–25.2)* 0.2 (0.1–0.4)*
Exactly 5 19.6 (11.7–33.0)* 0.1 (0.0–0.2)*
$6 32.1 (19.3–53.4)* 0.0 (0.0–0.0)*
x
2 (p-value)
c 579.0 (,0.001)* 50.9 (,0.001)*
aBivariate discrete time survival models include the following covariates: age, age-squared, age cohort, sex, and person-year.
bMultivariate interactive model (includes number of disorders and individual DSM-IV/CIDI disorders together in a discrete time survival model) includes the following
covariates: age, age-squared, age cohorts, sex, and person-year.
cThe group effect x
2 tests the set of coefficients for number of disorders for significance, while the individual x
2 only test presence versus absence of each specific
number of disorders.
*Significant at the 0.05 level, two-sided test. CI, confidence interval.
doi:10.1371/journal.pmed.1000123.t005
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predictive effect on ideation (OR=2.9) than on suicide plans
among ideators (OR=1.6), planned attempts among ideators
(OR=1.5), or unplanned attempts among ideators (OR=0.7). In
these countries, a number of disorders have stronger associations
with suicide ideation than depression, including: PTSD, bipolar
disorder, and conduct disorder (ORs=3.9), as well as intermittent
explosive disorder (OR=3.5), oppositional defiant disorder
(OR=3.2), drug abuse/dependence (OR=3.0), and dysthymia
(OR=3.0). Disorders characterized by anxiety and poor impulse-
control again emerged as the strongest predictors of planned
attempts (PTSD, OR=2.8; conduct disorder, OR=3.2), and the
only significant predictors of unplanned attempts (oppositional
defiant disorder, OR=3.1; alcohol abuse/dependence, OR=1.9).
PARPs
The findings reported so far present ORs for individual-level
associations that do not take into account either the prevalence of
the predictors or the distribution of comorbidity. Therefore, we
calculated PARPs to test population-level effects. PARPs represent
the proportion of cases with a suicide attempt that would be
prevented if specified predictor variables were eliminated (i.e.,
prevented), assuming that the predictors are causally related to
suicide attempts. For both developed and developing countries, the
Table 6. Multivariate survival models of associations between type/number of prior DSM-IV disorders and subsequent suicidal
behavior—developed countries.
Among Total Sample Among Ideators
Ideation Attempt Plan Planned Attempt Unplanned Attempt
DSM-IV Disorders OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
I. Anxiety disorders
Panic disorder 1.9 (1.5–2.5)* 2.3 (1.6–3.3)* 1.3 (1.0–1.8)* 1.3 (1.0–1.9) 1.8 (1.0–3.1)*
GAD 2.5 (2.0–3.1)* 2.5 (1.9–3.4)* 1.1 (0.8–1.4) 1.4 (1.0–1.9)* 1.7 (1.1–2.6)*
Specific phobia 1.9 (1.6–2.2)* 1.9 (1.5–2.4)* 1.2 (1.0–1.4) 1.3 (1.0–1.6)* 1.3 (0.9–1.8)
Social phobia 2.3 (2.0–2.8)* 1.9 (1.4–2.5)* 1.3 (1.0–1.6)* 1.2 (0.9–1.6) 1.0 (0.6–1.4)
PTSD 2.7 (2.2–3.2)* 3.0 (2.3–3.8)* 1.4 (1.1–1.8)* 1.4 (1.1–2.0)* 2.1 (1.3–3.3)*
SAD 1.9 (1.4–2.6)* 1.6 (1.2–2.1)* 1.2 (0.9–1.6) 1.2 (0.8–1.8) 1.3 (0.8–2.2)
Agoraphobia 2.2 (1.6–2.9)* 2.2 (1.4–3.4)* 1.3 (0.9–1.9) 1.4 (0.9–2.2) 0.7 (0.3–1.8)
II. Mood disorders
MDD 3.3 (2.8–3.9)* 3.2 (2.5–4.2)* 1.5 (1.2–1.8)* 1.5 (1.1–1.9)* 1.2 (0.8–1.7)
Dysthymia 2.1 (1.6–2.7)* 1.5 (1.0–2.2)* 1.1 (0.8–1.4) 0.8 (0.5–1.1) 1.2 (0.7–2.2)
Bipolar disorder 3.5 (2.7–4.6)* 3.5 (2.4–5.3)* 1.5 (1.1–2.0)* 2.6 (1.8–3.7)* 2.0 (1.1–3.6)*
III. Impulse–control disorders
ODD 2.2 (1.6–2.9)* 2.2 (1.6–3.0)* 1.3 (0.9–1.9) 1.7 (1.1–2.5)* 1.9 (1.1–3.3)*
Conduct disorder 2.2 (1.6–3.0)* 2.1 (1.4–3.0)* 1.0 (0.7–1.5) 1.1 (0.7–1.7) 2.2 (1.3–3.8)*
ADHD 1.7 (1.3–2.3)* 1.9 (1.3–2.7)* 1.6 (1.1–2.2)* 1.2 (0.9–1.8) 1.6 (0.8–3.2)
IED 2.1 (1.7–2.7)* 1.8 (1.2–2.5)* 1.1 (0.8–1.6) 1.3 (1.0–1.8)* 1.0 (0.6–1.7)
IV. Substance use disorders
Alcohol abuse or dependency 2.0 (1.7–2.4)* 2.6 (1.9–3.5)* 1.3 (1.0–1.7)* 1.3 (1.0–1.8)* 1.9 (1.2–3.1)*
Drug abuse or dependency 2.3 (1.7–3.0)* 2.0 (1.4–2.8)* 1.4 (1.1–1.9)* 1.2 (0.9–1.7) 1.0 (0.6–1.8)
V. Number of DSM-IV disorders
Exactly 2 0.8 (0.6–1.0) 1.1 (0.8–1.7) 1.1 (0.8–1.4) 0.9 (0.7–1.3) 0.9 (0.5–1.4)
Exactly 3 0.6 (0.4–0.8)* 1.0 (0.5–1.8) 1.0 (0.7–1.5) 1.0 (0.6–1.5) 0.7 (0.3–1.6)
Exactly 4 0.3 (0.2–0.5)* 0.5 (0.2–1.0) 0.9 (0.5–1.4) 0.9 (0.5–1.5) 0.6 (0.2–1.5)
Exactly 5 0.1 (0.1–0.3)* 0.2 (0.1–0.6)* 0.6 (0.3–1.1) 0.5 (0.2–1.1) 0.4 (0.1–1.5)
$6 0.0 (0.0–0.1)* 0.1 (0.0–0.2)* 0.6 (0.2–1.3) 0.3 (0.1–0.8)* 0.2 (0.0–1.2)
x
2
7 type (p-value)
a 308.6 (,.001)* 160.5 (,.001)* 31.7 (0.01)* 53.7 (,0.001)* 45.3 (,0.001)*
x
2
6 number (p-value)
b 150.4 (,.001)* 113.5 (,.001)* 12.5 (0.03)* 19.4 (0.002)* 6.0 (0.30)
(n)
c (27,963) (27,963) (4,997) (1,874) (3,123)
Each column includes a separate multivariate model in survival framework, with all rows as predictors controlling for the following covariates: age, age-squared, age
cohort, sex, and person-year.
ax
2 tests for significance of the set of coefficients for type of disorder net of effects of number.
bx
2 tests for significance of the set of coefficients for number of disorder net of effects of type.
cDenominator sample size of the models.
*Significant at the 0.5 level, two-sided test.
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; CI, confidence interval; GAD, Generalized Anxiety Disorder; IED, Intermittent Explosive Disorder; MDD,
Major Depressive Disorder; OCD, Obsessive Compulsive Disorder; ODD, Oppositional Defiant Disorder; SAD, Separation Anxiety Disorder.
doi:10.1371/journal.pmed.1000123.t006
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disorders on suicide attempts are largely due to effects on ideation
rather than on the transitions from ideation to plans or attempts.
Focusing first on PARPs for any mental disorder, analyses showed
that 59.2%–75.3% of all suicide attempts are associated with prior
DSM-IV disorder. Decomposition of this effect revealed that it is
due largely to the prediction of suicide ideation (60.9%–76.1%),
with much smaller PARPs for the onset of a suicide plan among
ideators (0.0%–4.7%), planned attempts among ideators (5.5%–
18.7%), and unplanned attempts among ideators (10.2%–17.6%)
(Tables 8 and 9). Mood and anxiety disorders played the largest role
in accounting for the onset of ideation in both developed and
developing countries. Anxiety disorders played the largest role in
accounting for attempts among ideators; however, the PARPs for
plans and attempts among ideators are consistently small for each
class of disorder (,10%). The occasional negative PARP values
associated with mood disorders in developing countries, although
indicating protective effects, are so small that they are more
reasonably interpreted as indicating that mood disorders have no
meaningful effects on these outcomes.
Table 7. Multivariate survival models of associations between type/number of prior DSM-IV disorders and subsequent suicidal
behavior—developing countries.
Among Total Sample Among Ideators
Ideation Attempt Plan Planned Attempt Unplanned Attempt
DSM-IV Disorders OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
I. Anxiety disorders
Panic disorder 2.5 (1.8–3.6)* 3.0 (1.7–5.4)* 1.3 (0.8–2.2) 1.9 (1.2–3.1)* 0.7 (0.2–2.4)
GAD 2.9 (2.1–4.1)* 2.9 (1.8–4.6)* 1.1 (0.8–1.7) 1.1 (0.7–1.9) 1.6 (0.6–3.9)
Specific phobia 2.2 (1.9–2.7)* 2.6 (2.0–3.4)* 1.4 (1.0–1.9)* 1.4 (1.0–1.9) 1.2 (0.8–1.8)
Social phobia 2.8 (2.2–3.5)* 2.9 (2.0–4.0)* 1.3 (0.9–1.9) 1.2 (0.7–1.9) 1.4 (0.8–2.5)
PTSD 3.9 (2.7–5.6)* 5.6 (3.5–8.8)* 2.1 (1.4–3.2)* 2.8 (1.7–4.6)* 2.0 (0.8–5.3)
OCD 1.9 (1.3–2.8)* 2.3 (1.3–4.2)* 1.0 (0.6–1.8) 1.7 (0.9–3.3) 0.8 (0.3–2.3)
SAD 2.4 (1.9–3.1)* 2.4 (1.7–3.4)* 0.9 (0.6–1.3) 1.2 (0.8–1.8) 1.6 (0.8–3.1)
Agoraphobia 1.8 (1.3–2.3)* 2.1 (1.4–3.0)* 1.3 (0.8–2.1) 1.4 (0.8–2.3) 1.7 (0.8–3.5)
II. Mood disorders
MDD 2.9 (2.4–3.5)* 3.2 (2.4–4.3)* 1.6 (1.2–2.1)* 1.5 (1.0–2.2)* 0.7 (0.4–1.2)
Dysthymia 3.0 (2.0–4.3)* 3.5 (1.9–6.6)* 1.2 (0.7–1.9) 1.6 (1.0–2.7) 2.1 (0.7–5.8)
Bipolar disorder 3.9 (2.7–5.7)* 3.2 (1.8–5.4)* 2.5 (1.5–4.1)* 1.2 (0.6–2.4) 0.8 (0.3–2.8)
III. Impulse-control disorders
ODD 3.2 (2.2–4.7)* 3.6 (2.0–6.5)* 2.0 (1.2–3.5)* 1.6 (0.9–2.8) 3.1 (1.3–7.3)*
Conduct disorder 3.9 (2.6–5.8)* 4.8 (2.5–9.1)* 2.0 (0.7–2.0) 3.2 (1.8–5.6)* 0.9 (0.3–2.3)
ADHD 2.2 (1.5–3.4)* 2.8 (1.6–4.9)* 1.0 (0.6–1.7) 1.7 (0.9–3.1) 1.8 (0.8–4.0)
IED 3.5 (2.7–4.3)* 3.3 (2.3–4.7)* 1.3 (1.0–1.9) 1.4 (0.9–2.1) 1.3 (0.7–2.3)
IV. Substance use disorders
Alcohol abuse or dependency 2.5 (2.0–3.2)* 3.7 (2.6–5.4)* 1.4 (1.0–2.0)* 1.4 (1.0–2.1) 1.9 (1.1–3.5)*
Drug abuse or dependency 3.0 (2.2–4.2)* 4.0 (2.5–6.4)* 1.7 (1.1–2.6)* 1.5 (0.9–2.8) 1.4 (0.5–4.0)
V. Number of DSM-IV disorders
Exactly 2 0.6 (0.5–0.8)* 0.7 (0.5–1.0) 1.3 (0.9–1.9) 0.8 (0.5–1.3) 0.6 (0.3–1.3)
Exactly 3 0.3 (0.2–0.5)* 0.3 (0.2–0.6)* 0.8 (0.4–1.3) 0.5 (0.3–1.0) 0.8 (0.3–2.5)
Exactly 4 0.1 (0.1–0.2)* 0.2 (0.1–0.4)* 0.7 (0.3–1.6) 0.4 (0.1–1.0)* 1.1 (0.3–4.4)
Exactly 5 0.1 (0.0–0.1)* 0.1 (0.0–0.2)* 0.9 (0.3–2.8) 0.3 (0.1–0.9)* 0.8 (0.1–5.2)
$6 0.0 (0.0–0.0)* 0.0 (0.0–0.0)* 0.3 (0.1–1.4) 0.1 (0.0–0.6)* 0.4 (0.0–5.1)
x
2
17 type (p-value)
a 312.8 (,0.001)* 159.3 (,0.001)* 45.5 (,0.001)* 48.6 (,0.001)* 21.1 (0.22)
x
2
6 number (p-value)
b 131.1 (,0.001)* 50.9 (,0.001)* 17.5 (0.004)* 9.2 (0.10) 5.3 (0.39)
(n)
c (26,959) (26,959)) (3,326) (1,438) (1,888)
Each column includes a separate multivariate model in survival framework, with all rows as predictors controlling for the following covariates: age, age-squared, age
cohort, sex, and person-year.
ax
2 tests for significance of the set of coefficients for type of disorder net of effects of number.
bx
2 tests for significance of the set of coefficients for number of disorder net of effects of type.
cDenominator sample size of the models.
*Significant at the 0.5 level, two-sided test.
Abbreviations: ADHD, Attention Deficit Hyperactivity Disorder; CI, confidence interval; GAD, Generalized Anxiety Disorder; IED, Intermittent Explosive Disorder; MDD,
Major Depressive Disorder; OCD, Obsessive Compulsive Disorder; ODD, Oppositional Defiant Disorder; PTSD, Posttraumatic Stress Disorder; SAD, Separation Anxiety
Disorder.
doi:10.1371/journal.pmed.1000123.t007
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Several noteworthy findings were revealed in this study. The
finding that approximately half of those who seriously consider
killing themselves, and more than half of those making a suicide
attempt have a prior mental disorder extends earlier findings from
psychological autopsy studies [43] and studies using clinical
samples [24,44] that have reported that most suicide attempters
have a diagnosable mental disorder. Notably, the rates of mental
disorder in the current study—even among suicide attempters—
were much lower than those documented in prior studies among
clinical samples and those dying by suicide, which suggests that the
rate of mental disorders among suicidal people in the general
population is lower than in these other groups. Moreover, we
examined lifetime mental disorders, whereas studies of suicide
decedents and clinical samples assess current or recent disorders,
making the differences between clinical and general population
studies even more pronounced.
Our finding of a lower rate of mental disorders among suicide
attempters in the general population is consistent with other recent
results indicating that prevalence estimates for suicide among those
with affective disorders differ on the basis of the treatment setting
from which participants are sampled (i.e., highest risk among
inpatients, lower risk among outpatients, and lowest risk among
the nonaffectively ill) [16]. The current study extends this finding
to other diagnoses. It also is notable in the current study that the
rate of mental disorders was slightly, but consistently, higher
among suicidal people in developed than developing countries.
However, rates of mental disorders were similarly lower among
nonsuicidal people from developing countries (see Tables S1–S4),
suggesting that there is a difference in the rate of mental disorders
in developed versus developing countries [32], rather than in the
association between disorders and suicidal behavior.
The presence of each mental disorder examined was associated
with increased odds of a subsequent suicide attempt. These results
extend findings from prior studies [12,24–26,45] by showing that
mental disorders in general are similarly predictive of suicide
attempts in developed and developing countries when similar
measurement methods are used cross-nationally. We also found
that while the ORs of virtually all temporally primary mental
disorders predict subsequent nonfatal suicide attempts, these ORs
vary significantly across disorders, demonstrating that type of
disorder makes a difference. In addition, we found that the relative
magnitudes of different types of disorders vary across stage of
progression to suicide attempts (i.e., in predicting onset of ideation
in the total sample, onset of plans among lifetime ideators, onset of
attempts among lifetime planners, onset of attempts among
lifetime ideators who never had a plan), which means that there
is no single underlying common pathway (e.g., an underlying
‘‘distress’’ factor) through which all disorders exert their effects on
the progression to attempts.
We also presented a more comprehensive analysis of the
association between comorbidity and suicidal behavior than
previously available, and several aspects of this association are
especially noteworthy. A strong dose-response relation was found
between the number of mental disorders present and the odds of a
subsequent suicide attempt, consistent with the results from several
prior studies [19,24,26,27]. In the current study, the presence of
multiple disorders (i.e., ‘‘multimorbidity’’ [46]) yielded ORs
several times higher than that for any individual disorder in the
prediction of suicide attempts. Despite this strong dose-response
relation, subadditive interactive effects were observed, suggesting
Table 8. PARP of DSM-IV disorders—developed countries.
Among Total Sample Among Ideators
DSM-IV Disorders Ideation Attempt Plan Planned Attempt Unplanned Attempt
Any mood disorder 0.620 0.586 0.007 0.073 0.056
Any anxiety disorder 0.293 0.326 0.015 0.086 0.045
Any impulse disorder 0.072 0.064 0.003 0.009 0.029
Any substance disorder 0.132 0.135 0.015 0.022 0.064
Any disorder 0.761 0.753 0.047 0.187 0.176
(n)
a (27,963) (27,963) (4,997) (1,874) (3,123)
aDenominator sample size.
doi:10.1371/journal.pmed.1000123.t008
Table 9. PARP of DSM-IV disorders—developing countries.
Among Total Sample Among Ideators
DSM-IV Disorders Ideation Attempt Plan Planned Attempt Unplanned Attempt
Any mood disorder 0.421 0.400 20.021 0.008 20.031
Any anxiety disorder 0.217 0.231 0.010 0.024 0.079
Any impulse disorder 0.111 0.097 0.007 0.009 0.023
Any substance disorder 0.114 0.098 0.009 0.013 0.034
Any disorder 0.609 0.592 0.003 0.055 0.102
(n)
a (26,959) (26,959) (3,326) (1,438) (1,888)
aDenominator sample size.
doi:10.1371/journal.pmed.1000123.t009
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number of comorbidities increases. This finding raises the
important possibility for intervention planning purposes that the
impact on reduced suicidality of successfully treating a single
disorder such as major depression or panic disorder will be greater
among people with pure than comorbid disorders. It also implies
that success in reducing suicidality by treating people with high
comorbidity will require treating multiple comorbid disorders
rather than only a single component disorder.
A top priority for future research should be to understand why
the joint predictive effects of comorbid disorders on suicidality are
as powerful as they are as well as why these associations are
subadditive. Prior research has shown that high comorbidity is
associated with high levels of psychological distress, impairment,
and disease burden [46,47], but has shed little light on the
dynamics of these associations. One possibility that has been
suggested in the literature is that high comorbidity creates an
especially intolerable situation from which people attempt to
escape via suicide [48,49]. However, if this were the case we would
expect to find that the joint effects of comorbid conditions are
supra-additive (i.e., the proverbial straw that broke the camel’s
back) rather than subadditive. Another possibility, as noted above
in the discussion of limitations, is that we misinterpreted disorder
complexity or severity as evidence of comorbidity. Future analyses
examining the influence of distress, impairment, and burden on
suicidal behavior should be conducted to investigate the effects of
pure and comorbid disorders on these intermediate outcomes
directly in order to help sort out alternative interpretations.
Illumination of the psychological mechanisms through which
comorbid mental disorders increase the risk of suicidal behavior is
sorely needed in order to explain the causal mechanisms leading to
suicide [50].
Even after accounting for the effects of comorbidity, however,
each disorder considered alone continued to significantly predict
subsequent suicide attempts. There has been debate regarding the
extent to which some disorders appear to be associated with
suicidal behavior only because they co-occur with other disorders
that are truly associated with suicidal behavior. For instance, prior
studies of the association between panic disorder and suicide
attempts have yielded different conclusions depending on which
comorbid disorders were controlled in each study [15,22,24]. We
controlled for comorbidity more rigorously than any prior studies
of which we are aware, and despite these controls panic disorder
continued to significantly predict suicide attempts cross-nationally
(ORs=2.3–3.0), suggesting that panic disorder is indeed uniquely
related to suicide attempts.
Consistent with results from prior studies, mood disorders—
particularly major depression and bipolar disorder—were signif-
icant predictors of suicide attempts with virtually the same ORs in
both developed and developing countries. Interestingly, however,
several other disorders were even stronger predictors of suicide
attempts in developing countries, including: conduct disorder,
oppositional defiant disorder, intermittent explosive disorder, drug
and alcohol abuse, and PTSD. The strong relation between
impulse-control disorders and suicide attempts in developing
countries extends results from a prior study using a subset of these
WMH countries [19]. The strong association between PTSD and
suicide attempts in developing countries is intriguing. Indeed,
PTSD was the strongest predictor of suicide attempts in
developing countries and was among the three strongest predictors
in developed countries. A few prior studies have noted a link
between PTSD and suicidal behavior [51,52]; however, PTSD has
received much less attention than mood and substance use
disorders as a risk factor for suicidal behavior. This finding may be
due to the lower base rate of PTSD in the population, even in
developing countries and those in which war exposure is more
common [53,54], which makes this association more difficult to
detect in smaller studies. Future studies should investigate whether
certain types of trauma, or characteristics of traumatic events,
might be particularly important in predicting suicidal behavior.
Overall, these findings underscore the importance of this broader
range of disorders in the onset of suicide attempts. A crucial goal
for future research is to better understand how and why such a
diverse range of disorders are uniquely associated with suicide
attempts.
As a first step toward doing so, we found that mental disorders
are differentially associated with suicidal behavior depending on
which part of the pathway to suicide was being predicted.
Specifically, each disorder is significantly associated with the
subsequent onset of suicide ideation. However, disorders were
much less useful in predicting which people with suicide ideation
progress to suicide plans and attempts, and many disorders were
not predictive of such progressions at all. Perhaps most
surprisingly, although depression has repeatedly been shown to
be among the strongest predictors of suicide attempts
[13,24,45,55] and was similarly predictive in the current study,
decomposition of this association revealed that it is due largely to
depression predicting the onset of suicide ideation. A diagnosis of
major depression is much less useful in predicting which people
with suicide ideation go on to make suicide plans or attempts, and
it is nonsignificantly associated with unplanned attempts in both
developed and developing countries. In contrast, disorders
characterized by anxiety (especially PTSD) and poor impulse-
control (especially bipolar, conduct, and substance use disorders)
emerged as the strongest predictors of which ideators make suicide
plans and attempts, and were especially useful in the prediction of
unplanned attempts. These findings do not suggest that depression
is unimportant in the prediction of suicidal behavior—indeed
many suicide attempts occur in the context of a depressive
episode—but only that a diagnosis of depression is not especially
useful in determining who is likely to act on their suicidal thoughts.
Several theoretical models have proposed that some disorders such
as depression lead people to desire suicide, and other disorders
characterized by anxiety/agitation and problems with impulse-
control increase the likelihood that people act on such thoughts
[56–60]. The current findings provide support for such a model
and show that this pattern of associations is consistent cross-
nationally. Future research is needed to investigate whether it is
indeed the impulsiveness, aggressiveness, and agitation associated
with these disorders that may lead to suicidal behavior—as has
been suggested in prior studies [61–63]—or if some other aspects
of these disorders account for the observed relations. This can be
tested by examining the associations between specific symptoms of
these disorders and suicidal behavior, and by testing whether the
observed effects are mediated by the psychological characteristics
proposed above (i.e., impulsiveness, etc.).
These results must be interpreted in light of several key
limitations. First, although the WMH achieved an acceptable
response rate overall, response rates varied cross-nationally.
Differential response was controlled for using poststratification
adjustments, but it remains possible that response rates were related
to the presence of suicidal behaviors or mental disorders, which
couldhave biasedcross-nationalcomparisons.Arelated limitationis
that although data are from large representative samples in 21
countries, several of the samples were not nationally representative,
and the WMH countries represent only a small sample from around
the globe. Each of these factors limits the generality of the results,
which should not be considered global estimates.
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occurrence and timing of mental disorders and suicidal behavior,
which introduce potential problems with underreporting and
biased recall [64]. Recall bias is likely to be greatest for history of
disorders typically diagnosed in childhood (e.g., Conduct Disorder,
Oppositional Defiant Disorder, Attention Deficit Hyperactivity
Disorder), which we attempted to address by limiting the diagnosis
of such disorders to those ,44 y old at the time of interview;
however, this does not fully negate this concern. It also is possible
that the extent of recall bias present differs across suicide ideation,
plans, and attempts, which could have influenced the study results.
On balance, systematic reviews have suggested that people can
recall past experiences with sufficient accuracy to provide valuable
information [65,66] and that such data are especially useful when
prospective data are not available [67], as in the current case. In
addition, the WMH clinical reappraisal studies, as noted in the
section on measures, found good concordance between diagnoses
based on the survey responses and diagnoses based on blinded
clinical follow-up interviews [38,39]. However, this evidence is not
convincing in light of the fact that the same recall bias could occur
in clinical interviews. The clinical reappraisal study did not assess
the concordance between survey measures of comorbidity and
assessments of comorbidity in the clinical follow-up interviews. In
addition, all clinical reappraisal studies were carried out in
developed countries. Parallel clinical reappraisal studies need to
be carried out in the future in developing countries. An additional
related limitation is that cultural factors may have influenced
willingness to report the presence of mental disorders or suicidal
behavior [68] as well as the interpretation of survey items about
these constructs [69,70].
Third, although we assessed a broad range of disorders and
various aspects of suicidal behavior, we did not consider the
severity, complexity, or chronicity of each disorder. This absence
could have led to an underestimate of the strength of associations
between mental disorders and suicidal behavior. For instance, it
may be that clinical severity and chronicity are important in
predicting the transition from suicide ideation to attempts. This
same problem could have led to an overestimate of comorbidity to
the extent that disorder complexity or severity was incorrectly
characterized as comorbidity in the CIDI. It is relevant in this
regard that fully structured lay-administered diagnostic interviews
like the CIDI are likely to be less capable of distinguishing between
secondary symptoms of complex disorders and true comorbidity,
making it likely that comorbidity is overdiagnosed and some of the
presumed predictive effects of comorbidity are actually effects of
disorder complexity or severity. This presumably explains why a
number of respondents were found to meet criteria for six or more
disorders, although the focus on lifetime hierarchy-free diagnoses
also contributed to this evidence for high comorbidity. A related
problem is that several disorders known to be associated with
suicidal behavior were not examined in this study, such as
nonaffective psychosis and personality disorders. The investigation
of these and other factors remain key directions for future
research.
Fourth, our analysis of comorbidity was restricted to a small
number of very simple models. It is possible that more subtle
interactions exist among disorders, which could be uncovered in
a comprehensive analysis. Given the enormous number of
logically possible interactions among the disorders considered
here, it might be useful for future research to use data mining
methods such as classification and regression tree analysis and
random forest analysis to search for consistent patterns among
these disorders [71–73]. Data mining has previously been used
successfully to study the joint interactive effects of a wide range
of risk factors for suicide attempts in a clinical sample [74].
Given the high risk of overfitting the data with methods of this
sort, though, it is important that future use of these methods in
the WMH data include cross-validation in random subsamples.
It will also be important for such future analyses to go beyond
the simple dichotomous comparison of developed versus
developing countries and to evaluate the consistency of
country-specific associations as well as explore plausible
interpretations of meaningful cross-national differences in
patterns of association.
Despite these limitations, the results of this study have important
implications for scientific, clinical, and policy efforts aimed at
suicide prevention. Scientifically, this study documents the
importance of controlling for comorbidity and of carefully
considering which suicidal behavior is being predicted in future
studies. Efforts to more carefully and precisely operationalize both
the independent and dependent variables in studies of suicidal
behavior will yield a clearer understanding of how and why such
behaviors occur. Clinically, these results demonstrate the impor-
tance of considering not only depression but also the full range of
mental disorders when evaluating patients’ risk for suicidal
behavior. Given the especially strong associations between multi-
morbidity and suicidal behavior, clinicians should always conduct
a suicide risk assessment among patients presenting with multiple
mental disorders.
From a public health perspective, the strong and consistent
associations between mental disorders and suicidal behavior
suggest that suicide prevention efforts should include a focus on
screening and treating mental disorders in both developed and
developing countries. Resources devoted to the treatment of
mental disorders in general, and suicidal behavior in particular,
currently are lacking in many developing countries [30,32,75].
Our results suggest that if there is infact acausal relationbetween
mental disorders and suicide attempts, allocating sufficient
resources to decrease mental disorders will lead to a significant
reduction in suicidal behavior. Although it is not yet known
whether a causal association exists, there is some evidence that
efforts to decrease the occurrence of mental disorders can
positively affect the suicide rate. For instance, some programs
designed to train primary care physicians in the recognition and
treatment of depression have demonstrated reductions in the
suicide rate [76–78]; however, not all such programs have
yielded positive effects [79]. Importantly, though, our results also
indicate that a sizeable minority of respondents report suicidal
behaviors in the absence of any mental disorder. Thus, focusing
solely on those with mental disorders is likely to miss a fairly large
segment ofthosewhoengageinsuicidalbehavior.Identifyingthis
subgroup is likely to be more challenging given that public health
programs that screen for the presence of mental disorders will not
identify these respondents, highlighting the need for novel
methods of identifying those at-risk that do not rely on the
presence of mental disorders [80]. There is still much we do not
know about how mental disorders and other factors increase the
risk of suicidal behavior; however, the results of this and related
studies highlight several important directions for improving the
understanding, prediction, and prevention of these dangerous
outcomes.
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Table S1 Prevalence of lifetime DSM-IV disorders among
suicidality in developed countries.
Found at: doi:10.1371/journal.pmed.1000123.s001 (0.02 MB
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Table S3 Multivariate survival models of interactive associations
between type and number of temporally primary lifetime DSM-
IV/CIDI disorders in predicting the subsequent first occurrence of
suicidal behaviors—developed countries.
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Table S4 Multivariate survival models of interactive associations
between type and number of temporally primary lifetime DSM-
IV/CIDI disorders in predicting the subsequent first occurrence of
suicidal behaviors—developing countries.
Found at: doi:10.1371/journal.pmed.1000123.s004 (0.02 MB
PDF)
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Background. Suicide is a leading cause of death worldwide.
Every 40 seconds, someone somewhere commits suicide.
Over a year, this adds up to about 1 million self-inflicted
deaths. In the USA, for example, where suicide is the 11th
leading cause of death, more than 30,000 people commit
suicide every year. The figures for nonfatal suicidal behavior
(suicidal thoughts or ideation, suicide planning, and suicide
attempts) are even more shocking. Globally, suicide
attempts, for example, are estimated to be 20 times as
frequent as completed suicides. Risk factors for nonfatal
suicidal behaviors and for suicide include depression and
other mental disorders, alcohol or drug abuse, stressful life
events, a family history of suicide, and having a friend or
relative commit suicide. Importantly, nonfatal suicidal
behaviors are powerful predictors of subsequent suicide
deaths so individuals who talk about killing themselves must
always be taken seriously and given as much help as possible
by friends, relatives, and mental-health professionals.
Why Was This Study Done? Experts believe that it might
be possible to find ways to decrease suicide rates by
answering three questions. First, which individual mental
disorders are predictive of nonfatal suicidal behaviors?
Although previous studies have reported that virtually all
mental disorders are associated with an increased risk of
suicidal behaviors, people often have two or more mental
disorders (‘‘comorbidity’’), so many of these associations may
reflect the effects of only a few disorders. Second, do some
mental disorders predict suicidal ideation whereas others
predict who will act on these thoughts? Finally, are the
associations between mental disorders and suicidal behavior
similar in developed countries (where most studies have
been done) and in developing countries? By answering these
questions, it should be possible to improve the screening,
clinical risk assessment, and treatment of suicide around the
world. Thus, in this study, the researchers undertake a cross-
national analysis of the associations among mental disorders
(as defined by the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition [DSM-IV]) and nonfatal suicidal
behaviors.
What Did the Researchers Do and Find? The researchers
collected and analyzed data on the lifetime presence and
age-of-onset of mental disorders and of nonfatal suicidal
behaviors in structured interviews with nearly 110,000
participants from 21 countries (part of the World Health
Organization’s World Mental Health Survey Initiative). The
lifetime presence of each of the 16 disorders considered
(mood disorders such as depression; anxiety disorders such
as post-traumatic stress disorder [PTSD]; impulse-control
disorders such as attention deficit/hyperactivity disorder; and
substance misuse) predicted first suicide attempts in both
developed and developing countries. However, the
increased risk of a suicide attempt associated with each
disorder varied. So, for example, in developed countries, after
controlling for comorbid mental disorders, major depression
increased the risk of a suicide attempt 3-fold but drug abuse/
dependency increased the risk only 2-fold. Similarly,
although the strongest predictors of suicide attempts in
developed countries were mood disorders, in developing
countries the strongest predictors were impulse-control
disorders, substance misuse disorders, and PTSD. Other
analyses indicate that mental disorders were generally more
predictive of the onset of suicidal thoughts than of suicide
plans and attempts, but that anxiety and poor impulse-
control disorders were the strongest predictors of suicide
attempts in both developed and developing countries.
What Do These Findings Mean? Although this study has
several limitations—for example, it relies on retrospective
self-reports by study participants—its findings nevertheless
provide a more detailed understanding of the associations
between mental disorders and subsequent suicidal
behaviors than previously available. In particular, its
findings reveal that a wide range of individual mental
disorders increase the chances of an individual thinking
about suicide in both developed and developing countries
and provide new information about the mental disorders
that predict which people with suicidal ideas will act on such
thoughts. However, the findings also show that only half of
people who have seriously considered killing themselves
have a mental disorder. Thus although future suicide
prevention efforts should include a focus on screening and
treating mental disorders, ways must also be found to
identify the many people without mental disorders who are
at risk of suicidal behaviors.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000123.
N The US National Institute of Mental Health provides
information about suicide in the US: statistics and
prevention
N The UK National Health Service provides information about
suicide, including statistics about suicide in the UK and
links to other resources
N The World Health Organization provides global statistics
about suicide and information on suicide prevention
N MedlinePlus provides links to further information and
advice about suicide and about mental health (in English
and Spanish)
N Further details about the World Mental Health Survey
Initiative and about DSM-IV are available
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